Request Deal Involvement

T. Rowe Price and Baillie Gifford led a $200m Series C funding round in DNA Script.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Alize RP

pr advisors

Alize RP

Seismic

pr advisors

Seismic

or

Principals

EUREKARE

bidder

EUREKARE

DNA SCRIPT

target

DNA SCRIPT

T. ROWE PRICE GROUP INC

bidder

T. ROWE PRICE GROUP INC

BAILLIE GIFFORD & CO

bidder

BAILLIE GIFFORD & CO

HEALTHCOR PARTNERS MANAGEMENT

bidder

HEALTHCOR PARTNERS MANAGEMENT

FIDELITY MANAGEMENT & RESEARCH COMPANY

bidder

FIDELITY MANAGEMENT & RESEARCH COMPANY

IRVING INVESTORS

bidder

IRVING INVESTORS

COATUE MANAGEMENT LLC

bidder

COATUE MANAGEMENT LLC

CATALIO CAPITAL MANAGEMENT

bidder

CATALIO CAPITAL MANAGEMENT

COLUMBIA THREADNEEDLE INVESTMENTS

bidder

COLUMBIA THREADNEEDLE INVESTMENTS

CASDIN CAPITAL

bidder

CASDIN CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - T. Rowe Price and Baillie Gifford led a $200m Series C funding round in DNA Script.